Eslohe, Germany

Sebastian Eilebrecht

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Sebastian Eilebrecht

Introduction

Sebastian Eilebrecht is a notable inventor based in Eslohe, Germany. He has made significant contributions to the field of medical diagnostics, particularly in relation to multiple sclerosis (MS). His innovative work has the potential to enhance the accuracy of MS diagnoses, thereby improving patient outcomes.

Latest Patents

Eilebrecht holds a patent for a method of diagnosing multiple sclerosis using a DNA-replication-associated (REP) protein. The patent, titled "Rep protein as protein antigen for use in diagnostic assays," describes a method where a blood sample from a patient is incubated with the REP protein. An increased amount of Rep protein or fragments in the sample, compared to a control sample, correlates with a diagnosis of MS. This invention represents a significant advancement in the diagnostic capabilities for this challenging condition.

Career Highlights

Throughout his career, Eilebrecht has worked with prestigious institutions, including the German Cancer Research Center (Deutsches Krebsforschungszentrum) and its associated foundation in Heidelberg. His work in these organizations has allowed him to contribute to groundbreaking research in cancer and other diseases.

Collaborations

Eilebrecht has collaborated with esteemed colleagues such as Harald Zur Hausen and Ethel-Michele De Villiers-Zur Hausen. These collaborations have further enriched his research and innovation in the field of medical diagnostics.

Conclusion

Sebastian Eilebrecht's contributions to the field of diagnostics, particularly in relation to multiple sclerosis, highlight his innovative spirit and dedication to improving healthcare. His patent and collaborations reflect a commitment to advancing medical science and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…